OBJECTIVE: To investigate the role of vascular endothelial growth factor (VEGF) in haemorrhagic fever with renal syndrome (HFRS). METHODS: VEGF, soluble VEGF receptor (sVEGFR)-2, angiopoietin (Ang)-1, tumour necrosis factor (TNF)-α and interferon (IFN)-γ levels were measured in serum samples from 68 patients with HFRS. Cultured human umbilical vein endothelial cells (HUEVCs) were infected by Hantaan virus (HTNV) and/or stimulated with recombinant VEGF; dextran permeability of the cells was determined. Claudin-1 and vascular endothelial (VE)-cadherin levels were determined by real-time reverse transcription-polymerase chain reaction and Western blot analyses. RESULTS: Serum VEGF, TNF-α and IFN-γ levels were significantly elevated, whereas sVEGFR2 and Ang-1 levels were reduced, during the acute phase of HFRS. In vitro cell permeability was unaffected by HTNV infection or VEGF stimulation alone, but the combination of HTNV infection and VEGF treatment significantly increased the permeability of endothelial cell monolayers in a time-dependent manner. Claudin-1 and VE-cadherin were downregulated at both the mRNA and protein level by combined HTNV infection and VEGF stimulation. CONCLUSIONS: Elevated VEGF induced by HTNV infection may play an important role in the vascular hyperpermeability that is characteristic of HFRS.
OBJECTIVE: To investigate the role of vascular endothelial growth factor (VEGF) in haemorrhagic fever with renal syndrome (HFRS). METHODS:VEGF, soluble VEGF receptor (sVEGFR)-2, angiopoietin (Ang)-1, tumour necrosis factor (TNF)-α and interferon (IFN)-γ levels were measured in serum samples from 68 patients with HFRS. Cultured human umbilical vein endothelial cells (HUEVCs) were infected by Hantaan virus (HTNV) and/or stimulated with recombinant VEGF; dextran permeability of the cells was determined. Claudin-1 and vascular endothelial (VE)-cadherin levels were determined by real-time reverse transcription-polymerase chain reaction and Western blot analyses. RESULTS: Serum VEGF, TNF-α and IFN-γ levels were significantly elevated, whereas sVEGFR2 and Ang-1 levels were reduced, during the acute phase of HFRS. In vitro cell permeability was unaffected by HTNV infection or VEGF stimulation alone, but the combination of HTNV infection and VEGF treatment significantly increased the permeability of endothelial cell monolayers in a time-dependent manner. Claudin-1 and VE-cadherin were downregulated at both the mRNA and protein level by combined HTNV infection and VEGF stimulation. CONCLUSIONS: Elevated VEGF induced by HTNV infection may play an important role in the vascular hyperpermeability that is characteristic of HFRS.
Authors: Shane Falcinelli; Brian B Gowen; Brett Trost; Scott Napper; Anthony Kusalik; Reed F Johnson; David Safronetz; Joseph Prescott; Victoria Wahl-Jensen; Peter B Jahrling; Jason Kindrachuk Journal: Mol Cell Proteomics Date: 2015-01-08 Impact factor: 5.911
Authors: Christopher D Hammerbeck; Rebecca L Brocato; Todd M Bell; Christopher W Schellhase; Steven R Mraz; Laurie A Queen; Jay W Hooper Journal: J Virol Date: 2016-06-24 Impact factor: 5.103
Authors: Ellen Krautkrämer; Christian Nusshag; Alexandra Baumann; Julia Schäfer; Jörg Hofmann; Paul Schnitzler; Boris Klempa; Peter T Witkowski; Detlev H Krüger; Martin Zeier Journal: BMC Infect Dis Date: 2016-11-14 Impact factor: 3.090
Authors: Shannon L Taylor; Victoria Wahl-Jensen; Anna Maria Copeland; Peter B Jahrling; Connie S Schmaljohn Journal: PLoS Pathog Date: 2013-07-18 Impact factor: 6.823
Authors: Emil Pal; Misa Korva; Katarina Resman Rus; Nataša Kejžar; Petra Bogovič; Franc Strle; Tatjana Avšič-Županc Journal: Emerg Microbes Infect Date: 2018-05-16 Impact factor: 7.163